JOHN MEADOWS: Open Payments
NPI 1245220193 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 25 payments from 10 companies in 2025. Trend: 2023 $228 · 2024 $504 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $184 |
| Madrigal Pharmaceuticals | 1 | $143 |
| Phathom Pharmaceuticals, Inc. | 5 | $71 |
| Ardelyx, Inc. | 2 | $40 |
| QOL Medical, LLC | 1 | $27 |
| Celltrion USA Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Intercept Pharmaceuticals, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| PFIZER INC. | 1 | $17 |
Products named: REZDIFFRA, RINVOQ, VOQUEZNA, CREON, IBSRELA, Sucraid, VEGZELMA, SKYRIZI.
Industry payments across NC — which companies pay providers there.
